Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) Research & Development (2016 - 2025)

Axogen has reported Research & Development over the past 16 years, most recently at $12.4 million for Q4 2025.

  • Quarterly results put Research & Development at $12.4 million for Q4 2025, up 84.61% from a year ago — trailing twelve months through Dec 2025 was $32.9 million (up 18.43% YoY), and the annual figure for FY2025 was $32.9 million, up 18.43%.
  • Research & Development for Q4 2025 was $12.4 million at Axogen, up from $7.6 million in the prior quarter.
  • Over the last five years, Research & Development for AXGN hit a ceiling of $12.4 million in Q4 2025 and a floor of $5.3 million in Q4 2022.
  • Median Research & Development over the past 5 years was $6.7 million (2023), compared with a mean of $6.9 million.
  • Peak annual rise in Research & Development hit 84.61% in 2025, while the deepest fall reached 17.79% in 2025.
  • Axogen's Research & Development stood at $6.3 million in 2021, then fell by 16.22% to $5.3 million in 2022, then surged by 35.89% to $7.2 million in 2023, then fell by 6.56% to $6.7 million in 2024, then skyrocketed by 84.61% to $12.4 million in 2025.
  • The last three reported values for Research & Development were $12.4 million (Q4 2025), $7.6 million (Q3 2025), and $6.9 million (Q2 2025) per Business Quant data.